BioNTech establishes Singapore's first mRNA vaccine manufacturing facility

Singapore was the German biotech company's clear choice for its Asia Pacific regional headquarters.

German biotechnology company BioNTech will establish its first mRNA manufacturing facility in Singapore, making it its regional headquarters in the Asia Pacific region.

BioNTech has partnered with Pfizer when it comes to the development of their mRNA COVID-19 vaccine.

Initial construction will begin this year, subject to planning approval, and the facility could be operational as early as 2023. The project has the support of the Singapore Economic Development Board.

"With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world," said BioNTech co-founder and CEO Ugur Sahin.

"Singapore provides an excellent business climate, growing biotechnology industry and rich talent base. We would like to thank Singapore’s Economic Development Board who has been very supportive throughout our planning process and we look forward to contributing our technology and expertise to the development of the biotechnology industry in Singapore and this region," he added.

The proposed Singapore manufacturing facility will be equipped with "cutting-edge manufacturing and digital infrastructure" to produce several novel mRNA vaccines and therapeutics for cancer and infectious diseases.

The site would be highly-automated and would have end-to-end mRNA production capabilities, to produce an estimated annual capacity of several hundred of millions of doses of mRNA-based vaccines, depending on the type.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia